Biofourmis is a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. They are pioneering an entirely new category of medicine, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics’ product pipeline across multiple therapeutic areas—including heart failure, oncology, acute coronary syndrome, COPD and chronic pain.

Biotechnology

Biofourmis

Jaydev Thakkar is the current Chief Operating Officer at [Biofourmis](/org/biofourmis). Prior to this, they were the Director of Digital Health and Innovation at [Amgen](/org/amgen) from January 2006 to January 2020. In this role, they led "beyond the therapy" digital innovation strategy to maximize product value and patient outcomes across the patient journey (Clinical Development through product launch and post-marketing) in partnership with cross-functional product leadership teams. Prior to their time at [Amgen](/org/amgen), Thakkar spent five years as a Senior Manager at [Capgemini](/org/capgemini) from January 2001 to December 2006. Jaydev also spent six years as a Senior Consultant at Sprint from January 2001 to January 2006, and one year as a Senior Consultant at [Charles Schwab](/org/charles-schwab) from March 2000 to December 2000. Thakkar is also a Co-founder of Brainvita Technologies Pvt. Ltd., where they served from September 1999 to December 2000. Finally, they are a Co-founder of Pragna Home Appliances Pvt. Ltd., where they served from January 1990 to December 1999.

Jaydev Thakkar has a Master of Business Administration from UCLA Anderson School of Management and a Master of Computer Applications from Gujarat University. Jaydev also has a Bachelor of Commerce in Finance, Accounting and Economics from M S University in Baroda.

Jaydev Thakkar reports to Kuldeep Singh Rajput, Founder & CEO. Jaydev Thakkar works with Maulik Majmudar - Co-Founder & Chief Medical Officer, Kirsten Carlson - Chief Marketing Officer, and Milan Shah - Chief Technology Officer.

Jaydev Thakkar

Matt Borowiecki is the current Chief Financial Officer at [Biofourmis](/org/biofourmis). Prior to this, they were the Director at Scottish Re representing [MassMutual](/org/massmutual) on their Board of Directors from August 2016 to February 2018. Before that, they were the Head of Financial Optimization Strategy at [MassMutual](/org/massmutual) from October 2013 to March 2020 where they built a team to develop ideas to optimize financial results and create value through capital markets, reinsurance and structured transactions, tax planning and similar projects. Additionally, they created a capital management 'tool kit' and cost of capital framework to inform capital decisions and successfully led a liability management transaction. Matt also priced the first surplus notes-backed contingent capital offering since 2008, an $800M 50NC30 P-Caps. Matt has also served as the Director of Corporate Development and Enterprise Strategic Planning at Aetna from August 2011 to October 2013, and as Vice President of Investment Banking in the Midwest Region at [Morgan Stanley](/org/morgan-stanley) from April 2007 to July 2011. Matt's career started as a Summer Associate in Investment Banking at UBS Investment Bank from June 2003 to August 2003.

Matt Borowiecki has a MBA from The Tuck School of Business at Dartmouth and a BA in Economics from [Kenyon College](/org/kenyon-college). Matt also attended The London School of Economics and Political Science (LSE).

They work with Maulik Majmudar - Co-Founder & Chief Medical Officer, Mark Niu - Co-Founder & Chief Privacy Officer, and Milan Shah - Chief Technology Officer. Matt Borowiecki reports to Kuldeep Singh Rajput, Founder & CEO.

Matt Borowiecki

Daniel Song is the current General Counsel at [Biofourmis](/org/biofourmis). Prior to this, they were Counsel at [Bird & Bird](/org/bird-bird) from December 2016 to June 2020. Daniel has also worked as an Associate at WongPartnership LLP from February 2014 to August 2016, and as a Lawyer at [Arnold Bloch Leibler](/org/arnold-bloch-leibler) from January 2010 to January 2014.

Daniel Song first completed a Bachelor of Laws (LLB) at [Monash University](/org/monash-university). Daniel then completed a Bachelor of Commerce (BCom), with a major in finance, also at [Monash University](/org/monash-university).

Daniel Song reports to Kuldeep Singh Rajput, Founder & CEO. Some of their coworkers include Sheeza Khawar Hussain - Chief Commercial Officer, Jaydev Thakkar - Chief Operating Officer, and Kirsten Carlson - Chief Marketing Officer.

Daniel Song

Kirsten Carlson is the Chief Marketing Officer at Biofourmis. Kirsten has over 25 years of experience in the pharmaceutical and biotechnology industries. Kirsten has held various leadership positions in marketing, sales, and business development. Kirsten has a proven track record in launching new products, building brand equity, and developing go-to-market strategies. Kirsten has a Bachelor of Science degree in Biology from the [University of Pennsylvania](/org/university-of-pennsylvania).

Kirsten Carlson has a background in consumer marketing strategy and competitive strategy, which they gained through executive education courses at Kellogg Executive Education and the University of Chicago Booth School of Business Executive Education. Kirsten also has a degree from the [University of Rhode Island](/org/university-of-rhode-island).

Their manager is Kuldeep Singh Rajput, Founder & CEO. Kirsten Carlson works with Denise Chittick - Chief Human Resources Officer, Jaydev Thakkar - Chief Operating Officer, and Matt Borowiecki - Chief Financial Officer.

Kirsten Carlson

Mark Niu

Denise Chittick

As chief medical officer, Majmudar oversees product management, data science and clinical affairs, with a focus on clinical validation and demonstrating outcomes for [Biofourmis](/org/biofourmis).

Maulik Majmudar

Kuldeep Singh Rajput is the CEO and Founder of [Biofourmis](/org/biofourmis), a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives.

Recognized as the “Forbes 30 Under 30”, Kuldeep has demonstrated strong leadership experience with building teams, developing talents, and successfully growing, and managing strategic partnerships with global pharmaceutical manufacturers, health systems and Payers.

Under his leadership, [Biofourmis](/org/biofourmis) has raised over US$45 Million in venture capital from leading Venture Capital firms including Sequoia Capital, MassMutual Ventures, Singapore Govt-linked [EDBI](/org/edbi), Aviva plc, and Mayo Clinic Ventures.

He uses his background and experience in biomedical engineering and data from the Massachusetts Institute of Technology (MIT) to unfold his vision of “Predicting and Preventing Serious Medical Events using AI”. During his Ph.D. studies at the [National University of Singapore](/org/national-university-of-singapore) (NUS), he built bioelectronic implants, which aim to control biological processes and treat diseases by modulating electric impulses.

Biofourmis

Org chart

Teams

Leadership Team

CEO and Executive Team

Founding Team

Discover similar companies